James Betler, DO
Radiation Oncology · Clairton, PANPI 1093967523
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $14,545 of the $19,398 with a category attached, or 75.0%. Sumitomo Pharma America, Inc. accounts for 64.7% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $12,589 and has fallen 97.4% since, to $331 in 2025. Among radiation oncology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 117 payments — averaging $165.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$13K
- Boston Scientific$4K
- Myovant Sciences Inc.$1K
- Novocure Inc.$540
- Elekta, Inc.$458
- Intuitive Surgical$259
- plus $721 from 6 others
What the payments were for
- Speaking & faculty fees$14,54575%
- Travel & lodging$8014%
- Food & beverage$4,05221%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 63 | $12,556 |
| Boston Scientific | 15 | $3,631 |
| Myovant Sciences Inc. | 20 | $1,232 |
| Novocure Inc. | 6 | $540 |
| Elekta, Inc. | 3 | $458 |
| Intuitive Surgical | 2 | $259 |
| AstraZeneca | 3 | $241 |
| Medivation Services LLC | 1 | $228 |
| Progenics Pharmaceuticals, Inc. | 1 | $124 |
| Carl Zeiss Meditec USA, Inc. | 1 | $69 |
| Novartis | 1 | $43 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORGOVYX$13,157
- SpaceOAR VUE System - 10mL$2,893
- SPACEOAR VUE$262
- Da Vinci Surgical System$259
- Optune$213
- ELEKTA MEDICAL LINEAR ACCELERATOR$147
- NovoTTF-100L$145
- SpaceOAR System$142
- PYLARIFY$124
- GENERAL - THERAPIES$123
- TAGRISSO$102
How this compares
$19,398 in reported general payments places this provider in the 90th percentile of 339 radiation oncology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 30 | $78,236 |
| Tamsulosin Hcl | 434 | $5,019 |
| Tolterodine Tartrate ErTolterodine Tartrate | 12 | $808 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Orgovyx | $12,556 | $78,23630 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 339 radiation oncology providers in Pennsylvania.
Other radiation oncology in Clairton
- Rodney WegnerClairton$7K
- Chirag ShahPittsburgh$344K
- Neil TaunkPhiladelphia$203K
- Wenyin ShiPhiladelphia$119K
- Navesh SharmaYork$106K
- Zachary HornePittsburgh$56K
- Yvonne MoweryPittsburgh$55K
- Kevin NeadPhiladelphia$50K
- Adam DickerPhiladelphia$46K
- Ajay BhatnagarHershey$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.